MPNs including polycythemia vera (PV), essential thrombocythemia (ET), and MF are characterized by overactive Jak/Stat pathway signaling, usually resulting from mutations in JAK2, MPL, or CALR. Here, JAK2 is linked to essential thrombocythemia.